PlainRecalls
FDA Drug Moderate Class II Terminated

Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.

Reported: December 17, 2014 Initiated: December 3, 2014 #D-0292-2015

Product Description

Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.

Reason for Recall

Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.

Details

Recalling Firm
Pfizer Inc.
Units Affected
31,569 HDPE Bottles
Distribution
Pfizer shipped the affected product to 4,447 direct accounts. No federal government accounts received the affected product directly from Pfizer Inc.
Location
New York, NY

Frequently Asked Questions

What product was recalled?
Tikosyn (dofetilide) 125 mcg (0.125 mg), a) 14-count bottle (NDC 0069-5800-61), b) 60-count bottle (NDC 0069-5800-60), Rx Only, Manufactured by Pfizer Labs, Division of Pfizer, Inc., NY, NY 10017.. Recalled by Pfizer Inc.. Units affected: 31,569 HDPE Bottles.
Why was this product recalled?
Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.
Which agency issued this recall?
This recall was issued by the FDA Drug on December 17, 2014. Severity: Moderate. Recall number: D-0292-2015.